DOI: http://dx.doi.org/10.18203/issn.2454-2156.IntJSciRep20191860

Facial paralysis probably related to systemic isotretinoin

Ömer Kutlu, İlknur Balta, Engin Karaarslan, Emine Esra Kıratlı Nalbant, Göğem İmren, Hatice M. Ekşioğlu

Abstract


We report a patient with severe acne who developed facial paralysis after two months of treatment with oral isotretinoin. Drug withdrawal resulted in a complete clinical recovery. Our case and a review of the literature indicate that oral isotretinoin might be capable of causing a dysfunction of predominantly sensory nerve fibers in some individuals. Clinicians should be aware of possible neurological sensorial symptoms during isotretinoin therapy.

 


Keywords


Facial paralysis, Isotretinoin, Drug withdrawal

Full Text:

PDF

References


Jindal SR. Isotretinoin with pulsed azithromycin and low dose oral isotretinoin alone in the management of moderate to severe acne. Int J Res Dermatol. 2018; 4(1):58-61.

al-Khawajah MM. Isotretinoin for acne vulgaris. Int J Dermatol. 1996;35(3):212-5.

Onder HI, Turan H, Kilic AC, Kaya M, Tunc M. Premacular hemorrhage due to isotretinoin use. Cutan Ocul Toxicol. 2013;32(2):170-2.

Laroche ML, Macian-Montoro F, Merle L, Vallat JM. Cerebral ischemia probably related to isotretinoin. Ann Pharmacother. 2007;41(6):1073-6.

Chroni E, Pasmatzi E, Monastirli A, Georgiou S, Katsoulas G, Polychronopoulos P, et al. Short-term oral isotretinoin therapy does not cause clinical or subclinical peripheral neuropathy. J Dermatolog Treat 2006;17(1):6-8.

Aydogan K, Karli N. Effects of oral isotretinoin therapy on peripheral nerve functions: a preliminary study. Clin Exp Dermatol. 2007;32(1):81-4.

Charalabopoulos K, Papalimneou V, Charalabopoulos A, Hatzis J. Two new adverse effects of isotretinoin. Br J Dermatol. 2003;148(3):593.

Fiallo P. Severe acute myopathy induced by isotretinoin. Arch Dermatol. 1996;132(12):1521–2.

Chroni E, Sakkis T, Georgiou S, Monastirli A, Pasmatzi E, Paschalis C, et al. Stiff-person syndrome associated with oral isotretinoin treatment. Neuromuscular Dis. 2002;12(9):886–8.

McCaffery P, Drager UC. Regulation of retinol acid signaling in the embryonic nervous system: a master differentiation factor. Cytokine Growth Factor Rev. 2000;11(3):233–49.